
A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
Chronic Kidney DiseasesHyperphosphatemiaThe goal of this clinical trial is to learn about the following questions in the patients receiving maintenance hemodialysis with elevated blood phosphorus: How much effect AP-306 has assessed by blood phosphorus lowering; How safe and tolerable AP-306 is. Participants will receive either following treatments: AP-306, and Sevelamer carbonate.

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized...
Pancreatic CancerThis trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The study will evaluate GI toxicity, overall survival, local control, quality of life, and workflow metrics.

Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease...
YawsCutaneous UlcerThe goal of this clinical trial is to test the non inferiority of linezolid compared with azithromycin as a treatment for yaws . The main questions it aims to answer are: can linezolid cure active yaws, and can linezolid cure latent yaws. Participants with serologically confirmed yaws will be randomized to receive linezolid (experimental) or azithromycin (control group) treatment and followed up to assess clinical resolution.

Safety and Efficacy of PMT Therapy of hPAP
Hereditary Pulmonary Alveolar ProteinosisThe major goal of this study is to evaluate a new type of cell transplantation therapy for individuals with hereditary PAP, study a new treatment that may be useful for treatment of other diseases, and research mechanisms that drive the development and function of lung macrophages.

Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory...
Triple-Negative Breast CancerThe study is being conducted to evaluate the Famitinib with Camrelizumab plus treatment of physician's choice (TPC) versus Camrelizumab plus TPC in Patients with Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer.

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
Metastatic Esophageal Squamous Cell CarcinomaThis study is a single-arm, prospective, phase II trial for patients with metastatic esophageal squamous cell carcinoma (ESCC) who received immunotherapy plus chemotherapy as the first-line treatment. The aim of the study is to determine if intervening with combined local therapy and immunotherapy and chemotherapy in patients with ESCC led to significant improvements in survival and disease control compared with historical data.

To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B...
Chronic Hepatitis bThis trial is a multi-center, open, single-dose, dose-increasing trial,to evaluate the safety and efficacy of STSG-0002 injection in patients with chronic hepatitis B treated with oral antiviral therapy.

Clinical Study of Light Therapy to Control Myopia Progression in Children
MyopiaProgressiveLow-lever red light therapy (LLLT) has been used to control myopia progression in China for a few years besides amblyopia therapy for a few decades. This study is to test the efficacy of PBM therapy to myopia children as well as to compare two types of PBM therapy to control myopia progression within one month.

An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Submental FatThis is a Phase 2, open-label study in which subjects seeking further improvement of their SMF will be treated with a second treatment session of RZL-012. The second treatment session will be offered to subjects previously treated with RZL-012 under protocols RZL-012-SMF-SWMTG-P2US-001 or RZL-012-SMFC-P2US-001. Subjects who fully completed either of the trials and whose C-CAT score is 2, 3 or 4 will be eligible to participate in the new trial. For each subject, the study will consist of a screening period, baseline period in which subjects will receive a second treatment session of RZL-012 and a follow-up period. RZL-012 will be administered during a single treatment session via multiple injections into the submental area under the chin. Subjects will thereafter be monitored for safety and efficacy for at least 84 days.

Reverse Walking With And Without Whole Body Vibration in Children With Cerebral Palsy
Cerebral PalsyTo determine the effects of reverse walking with and without Whole-body vibration on postural balance in children with cerebral palsy.